Literature DB >> 15037767

Analysis of the requirement for RNA polymerase II CTD heptapeptide repeats in pre-mRNA splicing and 3'-end cleavage.

Emanuel Rosonina1, Benjamin J Blencowe.   

Abstract

The carboxyl-terminal domain (CTD) of RNA polymerase II (pol II) plays an important role in coupling transcription with precursor messenger RNA (pre-mRNA) processing. Efficient capping, splicing, and 3'-end cleavage of pre-mRNA depend on the CTD. Moreover, specific processing factors are known to associate with this structure. The CTD is therefore thought to act as a platform that facilitates the assembly of complexes required for the processing of nascent transcripts. The mammalian CTD contains 52 tandemly repeated heptapeptides with the consensus sequence YSPTSPS. The C-terminal half of the mammalian CTD contains mostly repeats that diverge from this consensus sequence, whereas the N-terminal half contains mostly repeats that match the consensus sequence. Here, we demonstrate that 22 tandem repeats, from either the conserved or divergent halves of the CTD, are sufficient for approximate wild-type levels of transcription, splicing, and 3'-end cleavage of two different pre-mRNAs, one containing a constitutively spliced intron, and the other containing an intron that depends on an exon enhancer for efficient splicing. In contrast, each block of 22 repeats is not sufficient for efficient inclusion of an alternatively spliced exon in another pre-mRNA. In this case, a longer CTD is important for counteracting the negative effect of a splicing silencer element located within the alternative exon. Our results indicate that the length, rather than the composition of CTD repeats, can be the major determinant in efficient processing of different pre-mRNA substrates. However, the extent of this length requirement depends on specific sequence features within the pre-mRNA substrate.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15037767      PMCID: PMC1370548          DOI: 10.1261/rna.5207204

Source DB:  PubMed          Journal:  RNA        ISSN: 1355-8382            Impact factor:   4.942


  37 in total

1.  Participation of the C-terminal domain of RNA polymerase II in exon definition during pre-mRNA splicing.

Authors:  C Zeng; S M Berget
Journal:  Mol Cell Biol       Date:  2000-11       Impact factor: 4.272

2.  Capping, splicing, and 3' processing are independently stimulated by RNA polymerase II: different functions for different segments of the CTD.

Authors:  N Fong; D L Bentley
Journal:  Genes Dev       Date:  2001-07-15       Impact factor: 11.361

Review 3.  Coordination between transcription and pre-mRNA processing.

Authors:  P Cramer; A Srebrow; S Kadener; S Werbajh; M de la Mata; G Melen; G Nogués; A R Kornblihtt
Journal:  FEBS Lett       Date:  2001-06-08       Impact factor: 4.124

4.  SRm160 splicing coactivator promotes transcript 3'-end cleavage.

Authors:  Susan McCracken; Mark Lambermon; Benjamin J Blencowe
Journal:  Mol Cell Biol       Date:  2002-01       Impact factor: 4.272

Review 5.  An extensive network of coupling among gene expression machines.

Authors:  Tom Maniatis; Robin Reed
Journal:  Nature       Date:  2002-04-04       Impact factor: 49.962

6.  Requirements of the RNA polymerase II C-terminal domain for reconstituting pre-mRNA 3' cleavage.

Authors:  Kevin Ryan; Kanneganti G K Murthy; Syuzo Kaneko; James L Manley
Journal:  Mol Cell Biol       Date:  2002-03       Impact factor: 4.272

7.  Different phosphorylated forms of RNA polymerase II and associated mRNA processing factors during transcription.

Authors:  P Komarnitsky; E J Cho; S Buratowski
Journal:  Genes Dev       Date:  2000-10-01       Impact factor: 11.361

8.  Trans-activation by human immunodeficiency virus Tat protein requires the C-terminal domain of RNA polymerase II.

Authors:  H Okamoto; C T Sheline; J L Corden; K A Jones; B M Peterlin
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-15       Impact factor: 11.205

9.  Antagonistic effects of T-Ag and VP16 reveal a role for RNA pol II elongation on alternative splicing.

Authors:  S Kadener; P Cramer; G Nogués; D Cazalla; M de la Mata; J P Fededa; S E Werbajh; A Srebrow; A R Kornblihtt
Journal:  EMBO J       Date:  2001-10-15       Impact factor: 11.598

10.  Coupling of transcription with alternative splicing: RNA pol II promoters modulate SF2/ASF and 9G8 effects on an exonic splicing enhancer.

Authors:  P Cramer; J F Cáceres; D Cazalla; S Kadener; A F Muro; F E Baralle; A R Kornblihtt
Journal:  Mol Cell       Date:  1999-08       Impact factor: 17.970

View more
  26 in total

Review 1.  Multiple links between transcription and splicing.

Authors:  Alberto R Kornblihtt; Manuel de la Mata; Juan Pablo Fededa; Manuel J Munoz; Guadalupe Nogues
Journal:  RNA       Date:  2004-10       Impact factor: 4.942

2.  Transcription and splicing: when the twain meet.

Authors:  Yehuda Brody; Yaron Shav-Tal
Journal:  Transcription       Date:  2011 Sep-Oct

3.  Prolonged α-amanitin treatment of cells for studying mutated polymerases causes degradation of DSIF160 and other proteins.

Authors:  David C Tsao; Noh Jin Park; Anita Nag; Harold G Martinson
Journal:  RNA       Date:  2011-12-22       Impact factor: 4.942

4.  RNA polymerase II C-terminal domain phosphorylation patterns in Caenorhabditis elegans operons, polycistronic gene clusters with only one promoter.

Authors:  Alfonso Garrido-Lecca; Thomas Blumenthal
Journal:  Mol Cell Biol       Date:  2010-05-24       Impact factor: 4.272

5.  Role of the mammalian RNA polymerase II C-terminal domain (CTD) nonconsensus repeats in CTD stability and cell proliferation.

Authors:  Rob D Chapman; Marcus Conrad; Dirk Eick
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

6.  The C-terminal domain of RNA Pol II helps ensure that editing precedes splicing of the GluR-B transcript.

Authors:  Kicki Ryman; Nova Fong; Eva Bratt; David L Bentley; Marie Ohman
Journal:  RNA       Date:  2007-05-24       Impact factor: 4.942

7.  Exon skipping through the creation of a putative exonic splicing silencer as a consequence of the cystic fibrosis mutation R553X.

Authors:  Isabel Aznarez; Julian Zielenski; Johanna M Rommens; Benjamin J Blencowe; Lap-Chee Tsui
Journal:  J Med Genet       Date:  2007-05       Impact factor: 6.318

8.  Smicl is required for phosphorylation of RNA polymerase II and affects 3'-end processing of RNA at the midblastula transition in Xenopus.

Authors:  Clara Collart; Joana M Ramis; Thomas A Down; James C Smith
Journal:  Development       Date:  2009-10       Impact factor: 6.868

9.  Interferon regulatory factor 1 and a variant of heterogeneous nuclear ribonucleoprotein L coordinately silence the gene for adhesion protein CEACAM1.

Authors:  Kenneth J Dery; Craig Silver; Lu Yang; John E Shively
Journal:  J Biol Chem       Date:  2018-05-02       Impact factor: 5.157

Review 10.  Dynamic integration of splicing within gene regulatory pathways.

Authors:  Ulrich Braunschweig; Serge Gueroussov; Alex M Plocik; Brenton R Graveley; Benjamin J Blencowe
Journal:  Cell       Date:  2013-03-14       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.